After all, Genentech argued, U.S. District Judge Mariana Pfaelzer in L.A. has already presided over four cases involving the core patent — even going so far as to refer to herself as "a student of Cabilly II," as the Genentech patent is known.
Eli Lilly opposed the move, invoking a clause in its license agreement with Genentech providing that any disputes be litigated in the Northern District of California.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
